Rechallenge of ruxolitinib after momelotinib-related toxicity in a 74-yo woman with secondary myelofibrosis: a case report - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Reintroduction of ruxolitinib following toxicity from momelotinib in a 74-year-old female with secondary myelofibrosis: a case study

  • By

  • Jose Miguel Torregrosa Diaz

  • Laura Cailly

  • Maria Pilar Gallego Hernanz

  • Hélène Gardeney

  • Emilie Cayssials

  • July 1, 2026

Share

Original Source(s)

Related Content